Skip to main content

Table 3 Multivariate analysis

From: Circulating adipocyte fatty acid-binding protein is a predictor of cardiovascular events in patients with stable angina undergoing percutaneous coronary intervention

 

Univariate

Multivariate

Hazard ratio (95%CI)

p value

Hazard ratio (95%CI)

p value

A-FABP, per 1 ng/ml

1.02 (1.01–1.03)

< 0.01

1.03 (1.01–1.04)

0.01

Age, per 1 year

1.04 (1.01–1.07)

< 0.01

1.04 (1.01–1.08)

0.01

Men

1.41 (0.56–2.36)

0.72

–

 

Hypertension

1.47 (0.71–3.04)

0.29

–

 

Diabetes mellitus

1.01 (0.58–1.77)

0.97

–

 

Dyslipidemia

0.86 (0.46–1.62)

0.64

–

 

Smoking

0.99 (0.44–2.20)

0.98

–

 

Multivessel disease

1.71 (0.95–3.08)

0.08

1.71 (0.95–3.10)

0.08

CCBs

1.09 (0.63–1.92)

0.75

–

 

ACEIs/ARBs

1.54 (0.87–2.72)

0.14

–

 

Statins

1.25 (0.62–2.52)

0.53

–

 

Hypoglycemic agents

0.63 (0.32–1.23)

0.18

–

 
  1. CI confidence interval, A-FABP adipocyte fatty acid-binding protein, CCBs calcium channel blockers, ACEI angiotensin-converting enzyme inhibitor, ARB angiotensin II receptor blocker. Multivariate Cox proportional hazards analysis was then applied using covariates with p value < 0.1 in the univariate Cox proportional hazards analysis